LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $652 | -68.9% | 8,872 | -71.8% | 0.01% | -73.3% |
| Q4 2022 | $2,098 | -99.8% | 31,420 | +136.2% | 0.03% | +150.0% |
| Q3 2022 | $1,145,000 | -26.5% | 13,305 | +31.9% | 0.01% | +33.3% |
| Q4 2021 | $1,558,000 | +7.9% | 10,088 | +6.5% | 0.01% | -40.0% |
| Q1 2021 | $1,444,000 | +473.0% | 9,472 | +319.9% | 0.02% | +87.5% |
| Q2 2020 | $252,000 | +21.2% | 2,256 | +7.7% | 0.01% | -20.0% |
| Q3 2019 | $208,000 | -73.7% | 2,095 | -69.7% | 0.01% | -80.0% |
| Q2 2019 | $790,000 | – | 6,921 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |